Anixa Biosciences Inc (ANIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 10/31
| 10-2010 | 10-2009 | 10-2008 | 10-2007 | 10-2006 | |
| Sales | 731 | 1,056 | 2,063 | 487 | 509 |
| Cost of Goods | 82 | 66 | 96 | 160 | 156 |
| Gross Profit | 648 | 990 | 1,968 | 327 | 352 |
| Operating Expenses | 5,979 | 8,376 | 8,053 | 5,979 | 8,136 |
| Operating Income | -5,248 | -7,320 | -5,990 | -5,492 | -7,628 |
| Other Income | 73 | -9,169 | 168 | 34 | 27 |
| Pre-tax Income | -5,175 | -16,489 | -5,822 | -5,458 | -7,601 |
| Net Income Continuous | -5,175 | -16,489 | -5,822 | -5,458 | -7,601 |
| Net Income | $-5,175 | $-16,489 | $-5,822 | $-5,458 | $-7,601 |
| EPS Basic Total Ops | -0.75 | -3.00 | -1.25 | -1.25 | -2.00 |
| EPS Basic Continuous Ops | -0.87 | -2.97 | -1.12 | -1.32 | -1.99 |
| EPS Diluted Total Ops | -0.75 | -3.00 | -1.25 | -1.25 | -2.00 |
| EPS Diluted Continuous Ops | -0.87 | -2.97 | -1.12 | -1.32 | -1.99 |
| EBITDA(a) | $-5,240 | $-7,311 | $-5,982 | $-5,483 | $-7,613 |